Lyra - LYR

에 대한 최신 뉴스 Lyra Therapeutics (NASDAQ:LYRA) 주식

Lyra Therapeutics

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Fear and Greed

Pre-Market Outlook

FERG

LYRA

CNN 머니 공포와 탐욕 지수는 전반적인 시장 심리에 일부 개선을 보여주었고, 지수는 월요일에 &#34;탐욕&#34; 구역에 머물렀다. 미국 주식은 월요일에 상승세를 보였고, 나스닥 종합지수는 거래 세션 동안 100포인트 이상 상승했다.

무역 우려 재부상에도 나스닥 100p 이상 급등: 투자 심리 개선, 공포 지수는 &#39;탐욕&#39; 영역 유지

Binary,Options,Chart

Equities

News

Markets

APLD

GOOG

GOOGL

TSLA

미국 주식은 월요일에 상승세를 보였고, 다우 존스 산업 평균은 0.08% 상승하여 42,305.48로 마감했으며, S&amp;P 500은 0.4% 상승하여 5,935.94에, 나스닥은 거의 0.7% 상승하여 19,242.61에 도달했다. 다음은 하루 동안 소매 거래자와 투자자들의 주목을 받은 주요 주식들이다:

월요일 주목받은 주식: 어플라이드 디지털, 메타 플랫폼스, 알파벳, 리라 테라퓨틱스, 테슬라

Lyra Therapeutics Inc

A recent episode of &#8220;<a href="https://www.youtube.com/watch?v=L6398lZQHDk">The Ramsey Show</a>&#8221; took a sharp turn when a caller shared how his mother took out credit cards in his name after he and his brother bought her a home.
<h2 class="wp-block-heading">Mom Living In A Home Her Sons Bought, Son Holding The Bag</h2>
The caller, 27, explained that after his divorce, he was emotionally vulnerable and agreed to co-sign loans so his mom could buy the home she was living in. He and his brother put the mortgage in their names because his mom had <a href="https://www.benzinga.com/money/best-mortgage-lenders-for-poor-credit">poor credit</a>.
&#8220;She sucks blood off of her sons,&#8221; said Dave Ramsey after hearing the details. &#8220;She's a parasite. It's a horrible thing to say about your mother. I'm so sorry. Just an observation.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
The caller added that his mom makes minimal income and hasn't disclosed how much she earns. Meanwhile, she continues to make minimum payments on roughly $20,000 in credit card debt, all taken out under her son&#8217;s name.
"She's paying the mortgage," the caller said, but added that he constantly worries she'll stop. "I'm just waiting for the day that I get a call that, ‘Hey, your payment's due.'"
<h2 class="wp-block-heading">Selling The Home To Save The Marriage</h2>
Ramsey warned the caller that if he didn't take action quickly, this financial arrangement would result in deeper personal losses.
His advice? Sell the house. <a href="https://www.benzinga.com/money/best-ways-to-pay-off-credit-card-debt">Pay off all the credit cards</a>. Then, give his mom half of whatever equity remains. &#8220;You can go set yourself up a life with that,&#8221; he suggested.
Trending: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
Ramsey even gave him the script for the difficult conversation: &#8220;Mom, I love you, and I&#8217;ve done more for you than I should have, and I put myself and my future family in jeopardy because of you, and you continue to misbehave with this. My bills are not being paid, you&#8217;re destroying my credit and my future. We&#8217;re selling the house. Little brother, if you don&#8217;t want to sell it, you can buy me out.&#8221;
Ramsey also made it clear that the brother, who co-owns the home, should either buy him out or step aside. &#8220;If he doesn&#8217;t want to sell the house, then it&#8217;s going to be a civil court action and the judge is going to demand that the partnership be dissolved by the selling of the house,&#8221; Ramsey said.
&#8220;We&#8217;re selling the house. I&#8217;m not asking—we&#8217;re telling you. This is what we&#8217;re doing,&#8221; Ramsey added.
&#8220;This is saving your marriage, by the way,&#8221; Ramsey&#8217;s co-host, Jade Warshaw, said. The caller had just gotten married a month earlier, and this situation could become a major wedge. &#8220;Your wife is not going to sit around and let your mom be the reason that she&#8217;s not in her new house,&#8221; Warshaw added.
Read Next:
<ul class="wp-block-list">
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

Personal Finance

'She's A Parasite,' Says Ramsey To A Caller Who Bought Their Mom The Family Home—Then She Took Out Credit Cards In His Name

INAB

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

Tutor Perini (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPC#NYSE">TPC</a>) has outperformed the market over the past 5 years by 11.66% on an annualized basis producing an average annual return of 24.73%. Currently, Tutor Perini has a market capitalization of $2.05 billion. 
Buying $1000 In TPC: If an investor had bought $1000 of TPC stock 5 years ago, it would be worth $2,906.58 today based on a price of $38.89 for TPC at the time of writing.
<h3>Tutor Perini's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749167111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Tutor Perini 5 Years Ago Would Be Worth This Much Today

Sterling Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) has outperformed the market over the past 5 years by 64.11% on an annualized basis producing an average annual return of 77.18%. Currently, Sterling Infrastructure has a market capitalization of $5.94 billion. 
Buying $100 In STRL: If an investor had bought $100 of STRL stock 5 years ago, it would be worth $1,771.69 today based on a price of $195.24 for STRL at the time of writing.
<h3>Sterling Infrastructure's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749166275_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

STRL

$100 Invested In Sterling Infrastructure 5 Years Ago Would Be Worth This Much Today

Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) has outperformed the market over the past 5 years by 12.84% on an annualized basis producing an average annual return of 25.91%. Currently, Rhythm Pharmaceuticals has a market capitalization of $4.21 billion. 
Buying $100 In RYTM: If an investor had bought $100 of RYTM stock 5 years ago, it would be worth $318.94 today based on a price of $66.18 for RYTM at the time of writing.
<h3>Rhythm Pharmaceuticals's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749165311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RYTM

Here's How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years

Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) has outperformed the market over the past 10 years by 8.89% on an annualized basis producing an average annual return of 19.78%. Currently, Sprouts Farmers Market has a market capitalization of $16.32 billion. 
Buying $100 In SFM: If an investor had bought $100 of SFM stock 10 years ago, it would be worth $613.02 today based on a price of $166.77 for SFM at the time of writing.
<h3>Sprouts Farmers Market's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749164417_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Sprouts Farmers Market Stock In The Last 10 Years

Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) CEO Alex Karp expects the&nbsp;artificial intelligence&nbsp;arms race between the U.S. and China to have one winner.
Karp, on Thursday&#8217;s episode <a target="_blank" href="https://www.cnbc.com/2025/06/05/palantir-karp-ai-dangerous-china.html" rel="noreferrer noopener">of CNBC&#8217;</a>s &#8220;Squawk on the Street,&#8221; expressed his concerns regarding AI&#8217;s dangers while acknowledging its positive and negative consequences.
The stock is down amid reports indicating that some Republicans are criticizing the Trump administration&#8217;s deal with the company.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/45800099" rel="noreferrer noopener">Palantir CEO Alex Karp Refutes &#8216;Ridiculous&#8217; Surveillance Reports, Says Company Is &#8216;Winning&#8217;</a>
He had previously voiced aggressive efforts required by countries to develop more advanced AI models.
Karp said that no other economy in the world has corporate leaders as adaptable, tech-savvy, and open to innovation while still rooted in deep industry expertise. He added that Western allies, including those in Europe, must take notes from this approach.
He denied reports indicating that the company surveilled Americans to help the Trump administration gather data on Americans.
Palantir Technologies stock surged 435% in the last 12 months.
Reportedly, the Trump administration <a target="_blank" href="https://www.benzinga.com/news/contracts/25/05/45702431/palantir-stock-gains-as-trump-expands-companys-role-in-us-government-agencies" rel="noreferrer noopener">has&nbsp;recently expanded</a> the company&#8217;s&nbsp;work across the federal government.
Since Trump took office, Palantir bagged over $113 million in contracts (new and additional funds from existing), excluding the $795 million Department of Defense contract.
Price Action: PLTR stock closed lower by 7.77% at $119.91 on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45801143" target="_blank" rel="noreferrer noopener">Palantir Stock Falls As GOP Lawmakers Push Back On Government Surveillance Deal</a></li>
</ul>
Photo by slyellow via Shutterstock

Movers

Tech

Media

PLTR

Palantir CEO Warns US-China AI Race Will Have One Winner, Urges West To Keep Up

Interparfums (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPAR#NASDAQ">IPAR</a>) has outperformed the market over the past 20 years by 4.53% on an annualized basis producing an average annual return of 12.81%. Currently, Interparfums has a market capitalization of $4.39 billion. 
Buying $1000 In IPAR: If an investor had bought $1000 of IPAR stock 20 years ago, it would be worth $10,353.03 today based on a price of $136.66 for IPAR at the time of writing.
<h3>Interparfums's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749163517_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IPAR

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

Offerings

DOGZ

Dogness International Files For Resale Of Up To 1.2M Class A Common Shares By Selling Shareholders

ITT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITT#NYSE">ITT</a>) has outperformed the market over the past 5 years by 5.96% on an annualized basis producing an average annual return of 19.04%. Currently, ITT has a market capitalization of $12.20 billion. 
Buying $1000 In ITT: If an investor had bought $1000 of ITT stock 5 years ago, it would be worth $2,308.83 today based on a price of $149.82 for ITT at the time of writing.
<h3>ITT's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749162611_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning ITT Stock In The Last 5 Years

Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) has outperformed the market over the past 5 years by 15.93% on an annualized basis producing an average annual return of 29.0%. Currently, Piper Sandler has a market capitalization of $4.22 billion. 
Buying $1000 In PIPR: If an investor had bought $1000 of PIPR stock 5 years ago, it would be worth $3,628.92 today based on a price of $257.00 for PIPR at the time of writing.
<h3>Piper Sandler's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749161711_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PIPR

$1000 Invested In Piper Sandler 5 Years Ago Would Be Worth This Much Today

In the current market session, Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) share price is at $10.15, after a 0.20% increase. Moreover, over the past month, the stock fell by 10.65%, but in the past year, went up by 13.03%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749160832_0.png" alt="Past Year Chart" />

<h3>Garrett Motion P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Garrett Motion has a lower P/E than the aggregate P/E of 17.31 of the Automobile Components industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749160832_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Garrett Motion Inc's Price Over Earnings

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 15.05% on an annualized basis producing an average annual return of 26.96%. Currently, Cintas has a market capitalization of $92.31 billion. 
Buying $100 In CTAS: If an investor had bought $100 of CTAS stock 15 years ago, it would be worth $3,580.28 today based on a price of $228.62 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749160820_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

$100 Invested In Cintas 15 Years Ago Would Be Worth This Much Today

Space stocks are rising in Thursday&#8217;s after-hours session amid an escalation of a public dispute between SpaceX&#8217;s Elon Musk <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">and President Donald Trump</a>.
What Happened: Musk and Trump are throwing jabs on their respective social media platforms spurred by the former&#8217;s disapproval of a large tax bill being pushed by Trump. 
In a Truth Social <a href="https://truthsocial.com/@realDonaldTrump/posts/114632206992330264">post</a> Thursday afternoon, Trump said the easiest way to cut spending is to get rid of Musk&#8217;s government subsidies and contracts. 
Musk quickly <a href="https://x.com/elonmusk/status/1930718684819112251">responded</a> with a post on X, indicating that SpaceX would immediately start decommissioning its Dragon spacecraft, which is currently the only option the U.S. has for carrying crew members to the International Space Station. 
NASA press secretary Bethany Stevens chimed in on the dispute, noting that NASA will continue to work with Trump to carry out his vision for the future of space. 
&#8220;We will continue to work with our industry partners to ensure the President's objectives in space are met,&#8221; Stevens <a href="https://x.com/NASASpox/status/1930728558558900435?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1930728558558900435%7Ctwgr%5Ee06d105bd2067e7db775e61b4af3ebf6faa7e713%7Ctwcon%5Es1_&amp;ref_url=https%3A%2F%2Fwww.cnbc.com%2F2025%2F06%2F05%2Fmusk-trump-spacex-dragon-nasa.html">said</a> in an X post.
Space stocks appear to be rallying in response to the news as investors are optimistic the spat could create more opportunities for other space companies. 
Rocket Lab Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>), which has multiple <a href="https://www.benzinga.com/news/contracts/25/05/45434506/rocket-lab-gets-nasa-contract-to-launch-aspera-astrophysics-mission">contracts</a> with NASA, saw its shares rise 5.22% in Thursday&#8217;s after-hours session, while AST SpaceMobile Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares climbed nearly 3% at last check.
AST SpaceMobile is one of Jeff Bezos&#8217; Blue Origin's top customers. The companies signed a deal&nbsp;in November 2024 for the launch of up to 45 satellites. A Scotiabank analyst <a href="https://www.benzinga.com/news/space/25/06/45776611/ast-spacemobile-stock-climbs-after-analyst-flags-potential-investment-from-amazons-jeff-bezos">speculated this week</a> that the relationship between the two companies could get even stronger in the near future. 
Shares of heavily-shorted Virgin Galactic Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) were also up nearly 15% in after-hours at the time of writing.
The dispute between Musk and Trump comes about two weeks after Trump <a href="https://www.benzinga.com/general/space/25/05/45532125/l3harris-stock-moves-higher-after-being-named-in-golden-dome-missile-defense-system">announced</a>&nbsp;the architecture for a $175 billion Golden Dome missile defense system. The system will feature next-generation technologies, including &#8220;space-based sensors and interceptors&#8221; and &#8220;a lot&#8221; of American companies will be involved, according to Trump. 
The tax bill, referred to as Trump&#8217;s &#8220;big, beautiful bill&#8221; is expected to include $175 billion for the Golden Dome project.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45804512/trump-musk-feud-gets-ugly-etfs-exposed-with-tesla-caught-in-the-crossfire">Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire</a></li>
</ul>
Photo: courtesy of Rocket Lab.

SPACE

After-Hours Center

ASTS

RKLB

SPCE

Rocket Lab, AST SpaceMobile, Virgin Galactic Shares Are Rising After Hours: What's Going On?

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock traded down 14.3% to $284.70 on Thursday, the company's second-biggest percentage loss in more than a year and the biggest market cap loss in company history. The decline was<a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore" target="_blank" rel="noopener"> caused by an escalated feud between</a> CEO Elon Musk and President Donald Trump.
What Happened: Tesla's market cap fell by a company record $152 billion, taking the company out of the $1 trillion market capitalization club. This move comes after Musk <a href="https://www.benzinga.com/news/25/05/45635854/elon-musk-disappointed-with-trumps-big-beautiful-bill-says-it-undermines-the-work-that-the-doge-team-is-doing" target="_blank" rel="noopener">publicly criticized</a> Trump's "Big Beautiful Bill."
Comments made by Trump in a press interview and by Musk and Trump on social media accounts escalated the battle, with people picking sides in a war of words between two of the world&#8217;s most influential voices.
Musk has been vocal about the projected increase in the national debt from the new spending bill.
"Congress is spending America into bankruptcy!" the Tesla CEO tweeted.
Trump posted a series of messages on his Truth Social account speaking out against Musk.
"I don't mind Elon turning against me, but he should have done so months ago. This is one of the Greatest Bills ever presented to Congress," Trump <a href="https://truthsocial.com/@realDonaldTrump/posts/114632555927229642">posted</a>.
The president said the bill will put the country "on a path of greatness."
Another <a href="https://truthsocial.com/@realDonaldTrump/posts/114632205177163456">post </a>had Trump saying that he asked Musk to leave the White House as he was "wearing thin." The president said he removed Musk's EV mandate, which "forced everyone to buy electric cars that nobody else wanted."
"And he just went CRAZY!"
Trump also <a href="https://truthsocial.com/@realDonaldTrump/posts/114632206992330264">suggested </a>that terminating government subsidies and contracts with Musk would be one way to save money.
Musk <a href="https://x.com/elonmusk/status/1930698237650026675">said </a>the president&#8217;s comments on the EV mandate are "an obvious lie" in a tweet. The Tesla and SpaceX CEO also suggested that he will <a href="https://x.com/elonmusk/status/1930718684819112251">decommission </a>the Dragon spacecraft in response to Trump's threat on subsidies. The Dragon spacecraft was recently used to bring two stranded astronauts home from the International Space Station.
Musk also <a href="https://x.com/elonmusk/status/1930685402631053403">asked </a>if it was time to create a new political party in America that represents the "80% in the middle." With over 1.1 million votes in, 82% had voted yes, suggesting a third-party option to the Democratic and Republican parties.
Escalating the feud further, Musk <a href="https://x.com/elonmusk/status/1930703865801810022">tweeted </a>that the "really big bomb" is that Trump is in the Epstein files, a reference to the list of people associated with convicted sex offender Jeffrey Epstein.
Benzinga reached out to the White House for comment on Musk's accusation and did not hear back.
Musk also <a href="https://x.com/elonmusk/status/1930722828481098043">suggested </a>that Trump's tariffs "will cause a recession in the second half" of 2025.
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul class="wp-block-list">
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Tesla Stock Falls: Shares of the electric vehicle company suffered their second-largest fall year-to-date on Thursday, narrowly beaten by a 15.4% drop on March 10.
That March 10 drop was the largest percentage loss for Tesla shares in five years. The drop came as Musk's role in the White House expanded, and he said he planned to stay involved for another year. The stock had dropped in several sessions around that time amid tariff fears and concerns that Musk's political activism was damaging the Tesla brand.
While this marks Tesla&#8217;s largest market cap drop, it is also shy of the largest percentage drop in 2025 and all time.
The largest single-day percentage drop for Tesla stock was on Sept. 8, 2020, when it fell 21.1% after not being selected as a member of the S&amp;P 500 Index. The stock would later be added to the index.
Tesla stock fell 19.3% on Jan. 13, 2012 after two key departures were announced, as <a href="https://www.cnn.com/2020/09/08/investing/tesla-stock-plunge">reported </a>by CNN.
The good news for Tesla stock could be its history of rebounds after big drops. After shares fell 15.4% on March 10, 2025, the stock rose 3.8% the following day. After the record 21.1% drop on September 8, 2020, Tesla stock rose 10.9% the next day.
Tesla stock has traded between $167.42 and $488.54 over the last year, and it is now down 24.9% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/45795080/whatever-you-think-of-elon-musk-you-must-support-his-fight-against-the-big-beautiful-bill-says-black-swan-author-nassim-taleb">&#8216;Whatever You Think Of Elon Musk, You Must Support His Fight Against The Big Beautiful Bill,&#8217; Says &#8216;Black Swan&#8217; Author Nassim Taleb</a></li>
</ul>
Image created using photos from Shutterstock.

Politics

Management

Musk Vs. Trump: Tesla Suffers Record $152B One-Day Crash As CEO Warns Tariffs 'Will Cause A Recession'

Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) has outperformed the market over the past 15 years by 12.18% on an annualized basis producing an average annual return of 24.09%. Currently, Saia has a market capitalization of $6.75 billion. 
Buying $100 In SAIA: If an investor had bought $100 of SAIA stock 15 years ago, it would be worth $2,597.71 today based on a price of $253.45 for SAIA at the time of writing.
<h3>Saia's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749159917_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SAIA

Here's How Much You Would Have Made Owning Saia Stock In The Last 15 Years

General

HWBK

Hawthorn Bancshares Authorize The Repurchase Of Up To $10.0M  In Market Value Of The Company's Common Stock

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) released its first-quarter results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/06/n45802282/petco-health-wellness-company-inc-reports-first-quarter-2025-financial-results">details in the report. </a>
The Details: Petco Health and Wellness reported quarterly losses of four cents per share, which met the analyst consensus estimate. Quarterly revenue came in at $1.49 billion, missing the Street estimate of $1.5 billion and down from revenue of $1.53 billion from the same period last year.
Read Next:<a href="https://www.benzinga.com/markets/market-summary/25/06/45798808/trump-announces-china-trade-talks-tesla-stock-slumps-whats-driving-markets-thursday?utm_source=articleShare"> Trump Announces China Trade Talks, Tesla Stock Slumps: What&#8217;s Driving Markets Thursday?</a>
Petco reported: 
<ul class="wp-block-list">
<li>Net sales of $1.5 billion decreased 2.3% year-over-year in line with the company&#8217;s first quarter outlook.</li>
<li>Comparable sales decreased 1.3% year-over-year.</li>
<li>Gross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net sales.</li>
</ul>
&#8220;We are pleased to deliver first quarter earnings results ahead of our guidance and to reaffirm our outlook for fiscal 2025, which now incorporates the impact of tariffs. This performance is a testament to the execution of our nearly 30,000 team members and the resilience of the category in which we operate,&#8221; said Joel Anderson, Petco&#8217;s CEO.
WOOF Price Action: According to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>, Petco stock was down 10.77% at $3.23 at publication during Thursday's extended trading. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/social-media/25/06/45749596/the-viral-student-loan-solution-people-cant-stop-talking-about?utm_source=articleShare">Elon Musk&#8217;s Optimus Could Herald The Biggest Industry In History, Billionaire Investor Marc Andreessen Says</a></li>
</ul>
Photo: Shutterstock

Earnings

WOOF

Petco Stock Drops After Q1 Revenues Miss: Details

Sekisui House (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SKHSY#OTC">SKHSY</a>) GAAP EPS for Q1 2025 JPY 51.48 Down from JPY 77.80 YoY; Revenue JPY 894,044M Up from 777,052M YoY.

Earnings Misses

SKHSY

Sekisui House GAAP EPS for Q1 2025 JPY 51.48 Down from JPY 77.80 YoY; Revenue JPY 894,044M Up from 777,052M YoY.

Kadant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAI#NYSE">KAI</a>) has outperformed the market over the past 5 years by 10.79% on an annualized basis producing an average annual return of 23.86%. Currently, Kadant has a market capitalization of $3.81 billion. 
Buying $1000 In KAI: If an investor had bought $1000 of KAI stock 5 years ago, it would be worth $2,858.22 today based on a price of $323.55 for KAI at the time of writing.
<h3>Kadant's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749159021_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Kadant Stock In The Last 5 Years

Press Releases

Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present Study Results for LYR-210 and LYR-220 in Two Presentations at the ARS and AAO-HNS Annual Meetings

Health Care

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN 2 Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer

Lyra Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Analyst Ratings

Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Context Therapeutics

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Durect

Grace Therapeutics

Hoth Therapeutics

IGC Pharma

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

HC Wainwright & Co.

Jefferies

B of A Securities

BTIG

CNN 머니 공포와 탐욕 지수는 전반적인 시장 심리에 일부 개선을 보여주었고, 지수는 월요일에 "탐욕" 구역에 머물렀다.
미국 주식은 월요일에 상승세를 보였고, 나스닥 종합지수는 거래 세션 동안 100포인트 이상 상승했다.
월스트리트는 지난달 긍정적인 마감으로, S&amp;P 500이 5월에 6.2% 이상 상승하고 나스닥이 9.6% 급등하며 마감했다. 두 지수는 2023년 11월 이후 가장 강력한 달을 기록했다. 다우는 지난달에 3.9% 급등했다.
도널드 트럼프 대통령은 주말 동안 철강 및 알루미늄 수입에 대한 관세를 50%로 두 배 인상하겠다고 발표하며 중국과의 무역 긴장을 다시 불러일으켰다. 베이징은 워싱턴이 무역 협정을 심각하게 위반했다고 주장하며 자국의 이익을 방어하기 위해 강력한 조치를 취할 것이라고 다짐했다. 재개된 분쟁은 귀금속 및 산업 금속의 랠리를 촉발했다.
캠벨스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>)는 예상보다 나은 3분기 실적을 발표했다. 리라 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>)의 주가는 월요일에 회사가 LYR-210의 ENLIGHTEN 2 3상 시험에서 주요 목표를 달성했다고 발표한 후 310% 이상 급등했다.
경제 데이터 측면에서, ISM 제조업 PMI는 5월에 48.5로 하락했으며, 이는 4월의 48.7보다 감소한 수치로, 시장 예상치인 49.5에도 미치지 못했다. 미국의 건설 지출은 4월에 전월 대비 0.4% 감소하여 연율 기준으로 $2,152.4억이 되었고, 이는 수정된 3월의 0.8% 감소에 따른 결과다.
S&amp;P 500의 대부분 섹터가 긍정적인 마감세를 보였으며, 에너지, 통신 서비스 및 정보 기술 주식이 월요일에 가장 큰 상승폭을 기록했다. 그러나 산업 주식은 전체 시장 트렌드에 반하여 거래를 마감했다.
다우 존스는 월요일에 약 35포인트 상승하여 42,305.48로 마감했다. S&amp;P 500은 0.41% 상승하여 5,935.94에 이르렀고, 나스닥 종합지수는 월요일 세션 동안 0.67% 상승하여 19,242.61에 도달했다.
투자자들은 오늘 달러 제너럴(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>), 시그넷 주얼러스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) 및 퍼거슨 엔터프라이즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>)의 실적 발표를 기다리고 있다.
CNN 비즈니스 공포 및 탐욕 지수란?
현재 62.3의 수치를 기록한 지수는 월요일에 "탐욕" 구역에 머물렀고, 이전 수치는 61.6이었다.
공포 및 탐욕 지수는 현재 시장 심리를 측정하는 지표다. 이는 더 높은 공포가 주가에 압력을 가하고, 더 높은 탐욕이 그 반대의 효과를 미친다는 전제에 기반한다. 이 지수는 7개의 동등 가중 지표를 기반으로 계산된다. 지수는 0에서 100까지의 범위를 가지며, 0은 최대의 공포를, 100은 최대의 탐욕을 나타낸다.
다음 읽기: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45719976/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-and-telecom-stocks-delivering-high-dividend-yields-4">월스트리트의 가장 정확한 애널리스트들이 고배당 주식을 제공하는 3개의 기술 및 통신 주식에 대한 의견을 제시하다</a></li>
</ul>
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

무역 우려 재부상에도 나스닥 100p 이상 급등: 투자 심리 개선, 공포 지수는 '탐욕' 영역 유지

미국 주식은 월요일에 상승세를 보였고, 다우 존스 산업 평균은 0.08% 상승하여 42,305.48로 마감했으며, S&amp;P 500은 0.4% 상승하여 5,935.94에, 나스닥은 거의 0.7% 상승하여 19,242.61에 도달했다.
다음은 하루 동안 소매 거래자와 투자자들의 주목을 받은 주요 주식들이다:
어플라이드 디지털 코퍼레이션 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>)
어플라이드 디지털의 주가는 48.46% 급등하여 $10.14로 마감했다. 주가는 장중 최고 $10.54, 최저 $8.03를 기록했으며, 52주 범위는 $3.01에서 $12.48이다. 시간외 거래에서 주가는 거의 3.5% 상승했다. 이 회사는 코어위브(CoreWeave Inc.)와 약 15년간의 <a href="https://kr.benzinga.com/news/usa/stocks/%EC%96%B4%ED%94%8C%EB%9D%BC%EC%9D%B4%EB%93%9C-%EB%94%94%EC%A7%80%ED%84%B8-%EC%BD%94%EC%96%B4%EC%9C%84%EB%B8%8C%EC%99%80-ai-%EB%8D%B0%EC%9D%B4%ED%84%B0%EC%84%BC%ED%84%B0-%EA%B3%84%EC%95%BD%EC%9C%BC/" target="_blank" rel="noopener">장기 임대 계약</a>을 체결했다고 발표했다. 이 계약은 어플라이드 디지털의 노스다코타 데이터 센터에서 코어위브의 인공지능(AI) 및 고성능 컴퓨팅 인프라를 지원하기 위해 250메가와트의 중요한 IT 부하를 제공할 것이다.
메타 플랫폼스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
메타 플랫폼스는 3.62% 상승하여 $670.90로 마감했다. 주가는 장중 최고 $673.26, 최저 $644.26를 기록했으며, 52주 범위는 $442.65에서 $740.89이다. 이 회사는 2026년 말까지 AI로 구동되는 <a href="https://kr.benzinga.com/news/usa/stocks/%EC%98%A4%EB%8A%98-meta-%EC%A3%BC%EC%8B%9D%EC%9D%80-%EC%96%B4%EB%96%BB%EA%B2%8C-%EB%90%98%EA%B3%A0-%EC%9E%88%EB%82%98%EC%9A%94/" target="_blank" rel="noopener">완전 자동화된 광고 생성 시스템</a>을 출시할 준비를 하고 있다고 전해진다. 이 이니셔티브는 CEO 마크 저커버그의 AI 역량을 강화하고 광고 생성 및 전달 방식을 혁신하려는 전략의 일환이다.
참고: <a href="https://benzinga.com/news/politics/25/06/45716383/trump-administration-shuts-down-66-million-food-stamp-fraud-and-bribery-scheme-arrests-usda-employee-and-5-others" target="_blank" rel="noreferrer noopener">트럼프 행정부, 6,600만 달러 식품 보조금 사기 및 뇌물 수수 계획 중단, USDA 직원 및 5명 체포 &#8211; 벤징가</a>
알파벳 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)
알파벳의 클래스 A 주가는 1.6% 하락하여 $169.03로 마감했다. 주가는 최고 $169.87, 최저 $167.39를 기록했으며, 52주 범위는 $140.53에서 $207.05이다. 회사의 클래스 C 주가는 1.4% 하락하여 $170.37로 마감했다. 구글 검색의 가치에 대한 우려에도 불구하고, 골드만삭스의 애널리스트들은 알파벳이 AI 시대에 <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45726507/alphabet-set-to-gain-from-google-ai-innovation-underappreciated-youtube-goldman-sachs">전략적으로 유리하다</a>고 믿고 있다. 특히 구글 AI 및 유튜브 서비스와 관련하여 그렇다.
리라 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>)
리라 테라퓨틱스는 310.75%의 놀라운 상승세를 보이며 $20.25로 마감했다. 주가는 장중 최고 $37.50, 최저 $8.65를 기록했으며, 52주 범위는 $3.81에서 $37.50이다. 이 급등은 LYR-210의 ENLIGHTEN 2-3상 시험 결과 발표 후 발생했으며, 만성 비부비동염 치료에 있어 상당한 개선을 보여주었다. 주가는 시간외 거래에서 4.9% 상승했다.
테슬라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
테슬라의 주가는 1.09% 하락하여 $342.69로 마감했다. 주가는 장중 최고 $348.02, 최저 $333.33를 기록했으며, 52주 범위는 $167.42에서 $488.54이다. 이 회사는 BYD, 리오토(Li Auto), 니오(Nio), 그리고 샤오펑(Xpeng) 등 중국 전기차 제조업체들의 증가하는 경쟁에 직면해 있으며, 이들은 모두 5월의 강력한 <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45729188/tesla-stock-is-trading-lower-today-whats-going-on">출하량</a>을 보고했다.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" class="wp-image-935818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02215402/Screenshot-2025-06-03-at-10.53.47.png" sizes="(max-width: 441px) 100vw, 441px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02215402/Screenshot-2025-06-03-at-10.53.47.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02215402/Screenshot-2025-06-03-at-10.53.47-300x190.png 300w" alt="" width="441" height="279" /></a></figure>
벤징가의 엣지 주식 순위는 메타가 단기, 중기 및 장기적으로 긍정적인 가격 추세를 보이고 있음을 보여준다. 다음은 이 주식이 <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">다른 지표</a>에서 어떻게 평가되는지이다.
사진 제공: Billion Photos on Shutterstock.com
벤징가와 함께 <a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">상위 프리마켓 움직임 및 뉴스</a> 로 하루의 거래를 준비하라.
다음 읽기:
<ul class="wp-block-list">
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EC%BA%90%EC%8B%9C-%EC%9A%B0%EB%93%9C-%EC%A4%91%EA%B5%AD-%EB%9D%BC%EC%9D%B4%EB%B2%8C%EC%9D%98-%EC%84%B1%EC%9E%A5%EC%97%90-%ED%85%8C%EC%8A%AC%EB%9D%BC-%EC%A3%BC%EC%8B%9D-%EB%A7%A4%EA%B0%81-%EC%95%84/" target="_blank" rel="noopener">캐시 우드, 중국 경쟁자들이 점유율을 높이면서 테슬라 주식 매도 &#8211; 아크, 개인정보 보호 문제로 팔란티어 매각</a></li>
</ul>
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">벤징가 뉴로</a>에 의해 생성되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">시브딥 달리왈(Shivdeep Dhaliwal)</a>에 의해 편집되었다.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Lyra Therapeutics

뉴스

에 대한 최신 뉴스 Lyra Therapeutics (NASDAQ:LYRA) 주식

화요일, 6월 03, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌